Published in Platelets on October 31, 2013
Myelofibrosis with myeloid metaplasia. N Engl J Med (2000) 7.04
Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med (2003) 3.61
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood (2002) 3.06
Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood (1999) 2.61
A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1. Proc Natl Acad Sci U S A (1997) 2.55
Microparticles in hemostasis and thrombosis. Circ Res (2011) 2.26
GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med (2003) 1.96
Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A (2000) 1.90
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood (2006) 1.76
Bleeding and thrombosis in the myeloproliferative disorders. Blood (1984) 1.74
Soluble P-selectin and the risk of future cardiovascular events. Circulation (2001) 1.69
Effect of P-selectin on phosphatidylserine exposure and surface-dependent thrombin generation on monocytes. Arterioscler Thromb Vasc Biol (2005) 1.61
An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice. Proc Natl Acad Sci U S A (1997) 1.59
Multiple, targeted deficiencies in selectins reveal a predominant role for P-selectin in leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.55
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). Blood (2001) 1.51
Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol (2008) 1.40
Thrombosis in myeloproliferative disorders: prevalence, prognostic factors, and the role of leukocytes and JAK2V617F. Semin Thromb Hemost (2007) 1.38
Thrombosis in primary myelofibrosis: incidence and risk factors. Blood (2009) 1.37
Human phenotypes associated with GATA-1 mutations. Gene (2008) 1.24
Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. Exp Hematol (2005) 1.24
Platelet-leukocyte interactions in cardiovascular disease and beyond. Arterioscler Thromb Vasc Biol (2010) 1.23
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood (2006) 1.13
Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood (2000) 1.11
Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program (2012) 1.10
Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer (2009) 1.08
Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost (2009) 1.08
Front-line therapy in polycythemia vera and essential thrombocythemia. Blood Rev (2012) 1.07
Platelet-leukocyte interactions in thrombosis. Thromb Res (2011) 1.02
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Exp Hematol (2008) 1.02
Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis. Thromb Haemost (2009) 1.02
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria. Leukemia (2011) 1.00
Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost (2004) 0.99
Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome. Blood (2012) 0.96
Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost (2007) 0.96
Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Thromb Res (2002) 0.95
Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice. Blood (2002) 0.91
Ultrastructural characterization of maturation, platelet release, and senescence of human cultured megakaryocytes. Anat Rec (2000) 0.90
Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan. J Cardiovasc Pharmacol Ther (2011) 0.89
Frequency and risk factors for thrombosis in idiopathic myelofibrosis: analysis in a series of 155 patients from a single institution. Leukemia (2006) 0.89
Angiogenesis in P- and E-selectin-deficient mice. Microcirculation (1998) 0.89
Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation. Blood (2009) 0.87
Platelet - leukocyte interactions: multiple links between inflammation, blood coagulation and vascular risk. Mediterr J Hematol Infect Dis (2010) 0.86
P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. Trends Cardiovasc Med (2009) 0.84
Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis. Ann Hematol (2007) 0.81
Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation. Biotech Histochem (2010) 0.80
New insights into the pathogenesis of JAK2 V617F-positive myeloproliferative disorders and consequences for the management of patients. Semin Thromb Hemost (2006) 0.80
Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera. Int J Hematol (2004) 0.79
[X-linked thrombocytopenia with thalassemia in two families in Sweden. Consider hereditary causes of thrombocytopenia and bone marrow fibrosis]. Lakartidningen (2012) 0.77
Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice). Blood (2002) 3.06
GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J Exp Med (2003) 1.96
In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis (2002) 1.70
Pericyte coverage of abnormal blood vessels in myelofibrotic bone marrows. Haematologica (2007) 1.51
Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells (2006) 1.41
The use of India ink in tissue-simulating phantoms. Opt Express (2010) 1.23
Intralipid: towards a diffusive reference standard for optical tissue phantoms. Phys Med Biol (2010) 1.17
Increased and pathologic emperipolesis of neutrophils within megakaryocytes associated with marrow fibrosis in GATA-1(low) mice. Blood (2004) 1.15
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood (2006) 1.13
Penetration depth of light re-emitted by a diffusive medium: theoretical and experimental investigation. Phys Med Biol (2002) 1.12
Time-resolved diffuse reflectance using small source-detector separation and fast single-photon gating. Phys Rev Lett (2008) 1.12
Time-resolved reflectance at null source-detector separation: improving contrast and resolution in diffuse optical imaging. Phys Rev Lett (2005) 1.08
Humanized culture medium for clinical expansion of human erythroblasts. Cell Transplant (2010) 1.07
Measurements of optical properties of high-density media. Appl Opt (2003) 1.07
A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Blood (2005) 1.06
Pathological interactions between hematopoietic stem cells and their niche revealed by mouse models of primary myelofibrosis. Expert Rev Hematol (2009) 1.06
Abnormalities of GATA-1 in megakaryocytes from patients with idiopathic myelofibrosis. Am J Pathol (2005) 1.05
ARS Component B: structural characterization, tissue expression and regulation of the gene and protein (SLURP-1) associated with Mal de Meleda. Eur J Dermatol (2004) 1.05
Fat emulsions as diffusive reference standards for tissue simulating phantoms? Appl Opt (2012) 1.02
Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease. Exp Hematol (2008) 1.02
Induction of non-alcoholic fatty liver disease and insulin resistance by feeding a high-fat diet in rats: does coenzyme Q monomethyl ether have a modulatory effect? Nutrition (2009) 1.02
Calibration of scattering and absorption properties of a liquid diffusive medium at NIR wavelengths. CW method. Opt Express (2007) 1.02
Characterization of the TGF-β1 signaling abnormalities in the Gata1low mouse model of myelofibrosis. Blood (2013) 0.99
Erythroblast enucleation. Haematologica (2010) 0.99
Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia. Mol Pharmacol (2007) 0.97
Calibration of scattering and absorption properties of a liquid diffusive medium at NIR wavelengths. Time-resolved method. Opt Express (2007) 0.95
NF-E2 overexpression delays erythroid maturation and increases erythrocyte production. Br J Haematol (2009) 0.95
Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion. Stem Cells (2012) 0.94
In vivo time-resolved reflectance spectroscopy of the human forehead. Appl Opt (2007) 0.93
Role of GATA-1 in normal and neoplastic hemopoiesis. Ann N Y Acad Sci (2005) 0.93
The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients. Blood (2011) 0.92
Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds. Blood (2005) 0.91
Ionizing radiation induces apoptotic signal through protein kinase Cdelta (delta) and survival signal through Akt and cyclic-nucleotide response element-binding protein (CREB) in Jurkat T cells. Biol Bull (2009) 0.90
Interaction between the glucocorticoid and erythropoietin receptors in human erythroid cells. Exp Hematol (2009) 0.90
Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist. Fertil Steril (2006) 0.89
Absorption and scattering properties of carbon nanohorn-based nanofluids for direct sunlight absorbers. Nanoscale Res Lett (2011) 0.89
Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress. Stem Cells (2005) 0.88
Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem (2011) 0.88
Equivalence of four Monte Carlo methods for photon migration in turbid media. J Opt Soc Am A Opt Image Sci Vis (2012) 0.87
Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation. Blood (2009) 0.87
The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera. Haematologica (2009) 0.87
Perturbation theory for the diffusion equation by use of the moments of the generalized temporal point-spread function. I. Theory. J Opt Soc Am A Opt Image Sci Vis (2006) 0.87
Expression of signal transduction proteins during the differentiation of primary human erythroblasts. J Cell Physiol (2005) 0.86
Functional tomography using a time-gated ICCD camera. Biomed Opt Express (2011) 0.86
Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death. Blood Cells Mol Dis (2011) 0.85
Higher-order perturbation theory for the diffusion equation in heterogeneous media: application to layered and slab geometries. Appl Opt (2009) 0.85
EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One (2010) 0.85
Perturbation theory for the diffusion equation by use of the moments of the generalized temporal point-spread function. III. Frequency-domain and time-domain results. J Opt Soc Am A Opt Image Sci Vis (2010) 0.84
Effect of hypoxia and aging on PKC delta-mediated SC-35 phosphorylation in rat myocardial tissue. Anat Rec (Hoboken) (2009) 0.83
The expression of the glucocorticoid receptor in human erythroblasts is uniquely regulated by KIT ligand: implications for stress erythropoiesis. Stem Cells Dev (2012) 0.83
Recovery and Biodistribution of Ex Vivo Expanded Human Erythroblasts Injected into NOD/SCID/IL2Rγ mice. Stem Cells Int (2011) 0.82
Fast silicon photomultiplier improves signal harvesting and reduces complexity in time-domain diffuse optics. Opt Express (2015) 0.82
Phenotypic definition of the progenitor cells with erythroid differentiation potential present in human adult blood. Stem Cells Int (2011) 0.82
Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation. J Cell Biochem (2007) 0.82
Perturbation theory for the diffusion equation by use of the moments of the generalized temporal point-spread function. II. Continuous-wave results. J Opt Soc Am A Opt Image Sci Vis (2006) 0.82
CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin. J Cell Physiol (2010) 0.81
Effect of dependent scattering on the optical properties of Intralipid tissue phantoms. Biomed Opt Express (2011) 0.81
Evidence for organ-specific stem cell microenvironments. J Cell Physiol (2010) 0.81
Assessment of an in situ temporal calibration method for time-resolved optical tomography. J Biomed Opt (2003) 0.81
Role of thrombopoietin in mast cell differentiation. Ann N Y Acad Sci (2007) 0.80
Carbon nanohorn-based nanofluids: characterization of the spectral scattering albedo. Nanoscale Res Lett (2012) 0.80
Pathogenesis of myelofibrosis with myeloid metaplasia: lessons from mouse models of the disease. Semin Oncol (2005) 0.80
Impaired GATA-1 expression and myelofibrosis in an animal model. Pathol Biol (Paris) (2004) 0.80
Absorption and scattering perturbations in homogeneous and layered diffusive media probed by time-resolved reflectance at null source-detector separation. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.79
Probability density function of the electric field in diffuse correlation spectroscopy of human bone in vivo. Appl Opt (2016) 0.79
L-DOPA preloading increases the uptake of borophenylalanine in C6 glioma rat model: a new strategy to improve BNCT efficacy. Int J Radiat Oncol Biol Phys (2008) 0.79
Cyclic nucleotide Response Element Binding protein (CREB) activation promotes survival signal in human K562 erythroleukemia cells exposed to ionising radiation/etoposide combined treatment. J Radiat Res (2006) 0.79
Thrombopoietin inhibits murine mast cell differentiation. Stem Cells (2008) 0.79
Assessing the reliability of diffuse correlation spectroscopy models on noise-free analytical Monte Carlo data. Appl Opt (2015) 0.79
Interleukin-3 and erythropoietin cooperate in the regulation of the expression of erythroid-specific transcription factors during erythroid differentiation. Exp Hematol (2007) 0.79
Increased frequency of the glucocorticoid receptor A3669G (rs6198) polymorphism in patients with Diamond-Blackfan anemia. Blood (2011) 0.79
PKC alpha-mediated CREB activation is oxygen and age-dependent in rat myocardial tissue. Histochem Cell Biol (2006) 0.79
Compensated variability in the expression of globin-related genes in erythroblasts generated ex vivo from different donors. Transfusion (2009) 0.78
Spontaneous switch from Agamma- to beta-globin promoter activity in a stable transfected dual reporter vector. Blood Cells Mol Dis (2005) 0.78
Analytical solution of the correlation transport equation with static background: beyond diffuse correlation spectroscopy. Appl Opt (2016) 0.78